Rates of fetal loss and congenital anomalies were similar for participants on the rifapentine/moxifloxacin regimen and controls.
Categorised in: EID (Emerging Infectious Disease)
This post was written by senioradmin
Rates of fetal loss and congenital anomalies were similar for participants on the rifapentine/moxifloxacin regimen and controls.
Categorised in: EID (Emerging Infectious Disease)
This post was written by senioradmin
Comments are closed here.